Tectonic Therapeutic Announces Positive Interim Data from Phase 1b Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF
TX45 improved both left ventricular function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension in Heart Failure with preserved Ejection Fraction (“PH-HFpEF”), supporting ...
Tectonic jumps on positive data from early-stage trial for lead asset
Tectonic Therapeutic (TECX) stock surges on positive interim data from Phase 1b trial for lead candidate TX45 in patients ...
Robust Buy Rating for TX45 Amid Strong Data and Positive Outlook in Group 2 PH
In a report released yesterday, Tiago Fauth from Wells Fargo reiterated a Buy rating on Tectonic Therapeutic (TECX – Research Report), with a ...
Tectonic Therapeutic reports ‘positive’ data from Phase 1b trial for TX45
Tectonic Therapeutic (TECX) announced positive interim data from the Phase 1b acute hemodynamic clinical trial of its lead product candidate, ...
Tectonic Therapeutic Shares Hit 52-Week High After Positive Trial Data
Tectonic Therapeutic shares doubled, to $56.80, after the company said it saw positive interim data from a Phase 1b acute hemodynamic clinical trial of its lead product candidate, TX45, a long-acting, ...
bovnews6h
Tectonic Therapeutics’ (TECX) Stock Rockets: What’s Behind the Surge?
Tectonic Therapeutic is a biotechnology company focused on the development of novel therapies for cardiovascular diseases, particularly those involving pulmonary hypertension and heart failure. Its ...
Tectonic Therapeutic stock soars on positive trial data
The trial's safety results were reassuring, with no serious adverse events or significant changes in vital signs, physical exams, or safety laboratory values post-administration of TX45. Transient ...
TECX Stock Hits 52-Week High, Soaring to $53.6 Amid Market Optimism
TECX stock reached a new 52-week high this week, with shares trading at an impressive $53.6. According to InvestingPro data, analysts maintain a strong buy consensus with price targets ranging from ...
Nasdaq Moves Lower; Meta Platforms Posts Strong Sales
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite turning lower on Thursday. The Dow traded up 0.18% to 44,795.97 while the NASDAQ fell 0.25% to 19,583.83. The S&P 500 also ...
Dow Jumps Over 100 Points; Tesla Earnings Miss Views
European shares were higher today. The eurozone's STOXX 600 rose 0.6%, Germany's DAX 40 gained 0.2% and France's CAC 40 ...
manilatimes7h
Nasdaq Celebrates AI Company Wins In Home Health and Healthcare in Times Square
Nurses and home and health agency owners alike have told us that our AI powered app is a gamechanger. With our recent enterprise wins in this $130 Billion sector 1, we believe that we have a solution ...
IBM, UPS lead Thursday's market cap stock movers
Thursday's market has seen notable fluctuations among stocks, with significant movements in both the mega-cap and large-cap categories. As the trading day progresses, stocks such as IBM (NYSE:IBM) ...